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Abstract 
Background: Cancer stem cells (CSCs) constitute 1–2 % of cancer tissue and are a major cause of tumor metastasis 
and recurrence. The culture environment is important in maintaining CSCs in vitro. Sphere formation is one method of 
culturing CSCs. In this study, we identified and validated optimal culture conditions for sphere formation in hepatocel-
lular carcinoma cells.
Methods: Huh7 and HepG2 cells were plated in three different media types and were allowed to form spheres. To 
confirm the pluripotency of sphere cells, the expression of stem cell markers was evaluated. EpCAM, Connexin 32, and 
Connexin 43 expression was evaluated using reverse transcription-polymerase chain reaction (RT-PCR). The expression 
of E-cadherin, β-catenin, CD90, and CD133 was evaluated using immunocytochemistry. Flow cytometry was per-
formed to confirm the presence of stem cell markers CD133 and Connexin 32.
Results: Cells maintained in medium containing growth factors ((DMEM(+))GF) showed greater cell proliferation 
than cells in media with fetal bovine serum (FBS) (DMEM(+)FBS) or without FBS (DMEM(−)FBS). Cells cultured in 
DMEM(+)FBS medium exhibited greater proliferation after 20 days in culture than cells cultured under the other two 
conditions. Cells cultured in DMEM(−)FBS medium did not proliferate; therefore, this condition was removed from 
further analysis. RT-PCR and flow cytometry showed that sphere-forming cells cultured in DMEM(+)GF and DMEM(+)
FBS media had similar expression of stem cell markers.
Conclusion: Therefore, growth factor-free medium is an adaptable, efficient, and cost-effective tool for in vitro culti-
vation of CSCs.
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Background
Cancer stem cells (CSCs) play an important role in the 
formation, progression, and recurrence of malignant 
tumors [1]. CSCs comprise 1–2  % of cancer tissue and 
are particularly resistant to anticancer agents; instead of 
dying, CSCs become latent and then differentiate into 
cancer cells again, contributing to metastasis and uncon-
trolled growth.
The possibility that cancer may originate from stem cells 
was suggested by Cohnheim [2], and the theory has gained 
momentum with systematic study [3]. Hepatocellular carci-
noma (HCC), the fifth most common cancer in the world, 
is a malignant tumor that is the third most common cause 
of cancer-related death [4]. Although there are various treat-
ment methods for HCC, including surgical resection, liver 
transplant, chemotherapy, and radiation therapy, the cure 
rate is low, and the recurrence rate is high. CSCs are con-
sidered as the factors responsible for the cases of tumor 
relapse. Liver CSCs have been reported in multiple sub-
types of HCC and are considered as the master regulators of 
HCC initiation, tumor metastasis, and progression [5]. Drug 
therapies specifically targeting CSCs may be a more efficient 
cancer therapy for these patients. Therefore, researchers 
are attempting to identify the characteristics of CSCs using 
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cancer tissues and Huh7 cell lines from patients [6]. Studies 
have been conducted to elucidate the role of CSCs in liver 
cancer to reduce the high recurrence rate, but the findings 
are controversial regarding accurate stem cell markers and 
cell separation methods. These studies show that the meth-
ods to efficiently culture CSCs from cancer cells are lacking, 
and more effective culture conditions are required.
Sphere-forming culture was first used by Reynold and 
Weiss to isolate stem cells and has been widely used since 
[7]. In this technique, cells are attached to an extracellular 
matrix (ECM) that limits the growth, proliferation, and dif-
ferentiation of the cells. If cells cannot attach to the ECM 
and grow in suspension, they die through anoikis [3, 8]. 
However, cells with properties similar to stem cells are not 
affected by the ECM and can proliferate only through cell–
cell interaction. Using these properties, Reynold and Weiss 
achieved a free-floating sphere culture, called a neuro-
sphere culture, using stem cells obtained from the human 
brain [7]. CSCs are similar to stem cells in that the former 
can differentiate into cancer cells. Cell-surface markers 
expressed in stem cells such as CD133, CD44, and CD90 
are also expressed in liver CSCs [9–11]. Cells growing 
under sphere-forming conditions also have increased via-
bility. The sphere-forming culture method has been used 
to proliferate stem cells in solid cancers such as those of 
the breast and ovary [12]. Under the ECM-attached condi-
tion, the survival rate of cancer cells in a sphere-forming 
culture was higher than that in a monolayer culture. In 
addition, several stem cell markers such as oct4, ov6, and 
CD133 were more highly expressed. When cells obtained 
from sphere-forming culture methods were transplanted 
into mice, cancer formed more readily than when using an 
equal number of cells grown in a monolayer [13].
One of the most important components of sphere-form-
ing culture is the optimal culture medium. The culture 
medium used in monolayer culture is generally different 
from that used in sphere-forming culture. Sphere-forming 
culture medium is serum-free and supplemented with 
several growth factors, including epidermal growth fac-
tor (EGF), basic fibroblast growth factor (bFGF), b27 sup-
plement, and others. The concentration of growth factors 
added is different for different types of cells, and the effect 
of each growth factor is also distinct. For example, EGF 
signaling is activated by EGF receptors and is known to play 
an important role in maintaining pluripotency in neuro-
glioma stem cells [14]. FGF is known to play an important 
role in creating tumor spheres and increasing side popula-
tion which is sub-population of cells that is distinct from 
the main population on the basis of the markers employed 
[15]. b27 plays a role in forming tumor spheres and in 
maintaining the characteristics of sphere-forming cells [16].
There are cancer cells in which the sphere-forming 
growth of CSCs is possible without the addition of 
growth factors. Glioblastoma stem cells, for example, are 
known to proliferate with only autocrine factors even in 
the absence of external growth factors [17].
In the current study, sphere formation of Huh7 and 
HepG2 cells was evaluated in culture media with and 
without growth factors. Culture conditions potentiat-
ing optimal sphere formation, while also maintaining the 
stem cell characteristics of CSCs, were established.
Results
Sphere formation in Huh7 and HepG2 cells
Sphere formation was evaluated in the three types of 
media, DMEM(+)GF, DMEM(+)FBS and DMEM(−)
FBS. Sphere formation began in DMEM(+)GF and 
DMEM(+)FBS cultured cells on day 5 (data not shown). 
Cells cultured in DMEM(−)FBS, which lacked FBS and 
growth factors, did not form spheres and died in cul-
ture. The morphology of DMEM(+)GF and DMEM(+)
FBS cultured spheres were similar to each other. The 
sphere-forming cells started to attach to each other on 
day 7 under both conditions, respectively. The size of 
DMEM(+)GF and DMEM(+)FBS cultured cells was 
not increased, but their form was maintained HepG2 
sphere-forming cells were similar with Huh7 cells 
(Fig. 1a, b).
Analysis of the self‑renewal of Huh7 and HepG2 
sphere‑forming cells
The cell proliferation rates of the DMEM(+)GF and 
DMEM(+)FBS groups were not significantly different 
after 3 day, but the proliferation of sphere-forming cells 
in DMEM(+)GF was significantly increased after 7 days. 
Increased proliferation rates of sphere-forming cells in 
DMEM(+)FBS was not observed until day 7 and could be 
observed through day 15.
After 2  weeks in culture, the proliferation rate of the 
cells in DMEM(+)GF decreased, but proliferation of 
the cells in DMEM(+)FBS increased again by day 20. 
Although in the DMEM(+)GF, the number of HepG2 
sphere-forming cells increased until day 7, number of 
HepG2 sphere-forming cells in DMEM(+)FBS did not 
increase until day 7 and increased between days 7 and 
15. After day 15, the number of HepGe2 sphere-forming 
cells decreased in both culture conditions. Sphere forma-
tion did not occur in the cells in DMEM(−)FBS, and the 
cells did not proliferate (Fig. 1c, d).
Expression of cancer stem cell markers in Huh7 
sphere‑forming cells
Expression of pluripotency and CSC marker genes 
were measured using RT-PCR. Initially, the expres-
sion of pluripotency genes in Huh7 and HepG2 cells 
were higher in DMEM(+)GF; however, as the culture 
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period progressed, expression of pluripotency genes in 
DMEM(+)GF and DMEM(+)FBS-cultured cells became 
similar. The expression of epithelial cell adhesion mol-
ecule (EpCAM), a gene expressed in CSCs, was similar 
between the two groups. The expression levels of Con-
nexin 32 and 43, which are involved in the proliferation 
and growth of hepatoma cells, were also not significantly 
different (Fig. 2).
Expression of CSC surface proteins in Huh7 sphere‑forming 
cells
Cancer stem cells surface markers CD133 and CD90 were 
both expressed at two culture media. Beta-catenin, which 
is involved in the proliferation of CSCs, was expressed on 
days 7 and 15, but the cells in DMEM(+)FBS expressed 
relatively more β-catenin on day 20. E-cadherin, which is 
involved in the physical association of cells, was hardly 
expressed in DMEM(+)FBS cells on day 7, but was 
expressed at two culture media on days 15 and 20. In 
HepG2 sphere-forming cells, CSC surface markers were 
expressed in both media. Because there was almost no 
difference between the expression of stem cell markers 
of cells grown in the DMEM(+)GF and DMEM(+)FBS, 
it can be inferred that growth factors did not influence 
these characteristics of the cells (Fig. 3).
Fig. 1 Optical microscopy and proliferation analysis of Huh7 spheres in DMEM(+)GF, DMEM(+)FBS and DMEM(−)FBS medium on days 3, 7, 15, and 
20. Hepatocellular carcinoma cell lines, including a Huh7 and b HepG2, could form the spheres in DMEM(+)GF and DMEM(+)FBS medium. Scale 
bar 100 µm, scale bar 100 µm. Huh7 and HepG2 cells were cultured in three media types (DMEM(+)GF, DMEM(+)FBS and DMEM(−)FBS media) and 
were observed over time. Cells were not adhered to culture plates but grew in suspension and formed spheres. Cells in DMEM(+)GF and DMEM(+)
FBS media formed spheres that were similar in size, which increased after day 15. Cells in the DMEM(−)FBS medium died and were excluded from 
further analyses. The proliferation of sphere-forming cells in DMEM(+)GF, DMEM(+)FBS and DMEM(−)FBS was compared over time. Cells were 
analyzed on days 3, 7, 15, and 20 using a CCK-8 kit. c The Huh7 sphere-forming cells showed a cell proliferation. d The HepG2 sphere-forming cells 
showed a cell proliferation. After 3 days in culture, the proliferation of sphere-forming cells in DMEM(+)GF medium was increased. After 7 days in 
culture, the proliferation of DMEM(+)GF and DMEM(+)FBS media cultured cells became similar. b The HepG2 sphere-forming cells showed a cell 
proliferation. Cells in DMEM(+)FBS media were increased for 15 days and in DMEM(+)GF media decreased from 7 days
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Pluripotency markers expressed in Huh7 and HepG2 
sphere‑forming cells
Oct4, Nanog, and Sox2 are pluripotency markers. The 
number of cells expressing each marker was small on day 
7, but gradually increased after day 15. On day 20, cells 
in both the DMEM(+)GF and DMEM(+)FBS expressed 
these markers similarly.
Stem cell markers were not expressed early in sphere 
formation; however, as the culture time progressed, 
proliferation and the number of cells expressing Oct4, 
Nanog, and Sox2 were increased. In addition, because 
stem cell marker expression was similar between the 
DMEM(+)GF and DMEM(+)FBS-cultured cells, it 
can be concluded that growth factors do not affect the 
expression of these genes under these conditions (Fig. 4a, 
b).
Cancer stem cell markers expressed in Huh7 and HepG2 
sphere‑forming cells
The expression levels of Connexin 32 and CD133 were 
measured by flow cytometry. In Huh7 sphere-forming 
cells, DMEM(+)GF and DMEM(+)FBS cultured cells 
exhibited similar levels of Connexin 32 expression, which 
decreased over time. The ratio of Connexin 32 presenting 
cells in HepG2 sphere-forming cells was small compared 
to the ratio of Connexin 32 cells in the Huh7 sphere-
forming cells. However, the number of total presenting 
cells decreased as the days of culture increased.
The expression of CD133, a marker of CSCs, was meas-
ured on days 7 and 15 of sphere-forming culture, and 
the results were similar under the two culture media. 
On day 20, cells under both media conditions showed a 
decreased amount of cells expressing CD133 (Fig. 4c, d). 
Therefore, these data suggest that sphere-forming culture 
without growth factors is possible without significantly 
affecting cell pluripotency and proliferation.
Discussion
Sphere-forming culture methods, in which cells are cul-
tured in a suspended state, have been used to prolifer-
ate adult stem cells such as prostate and mammary cells 
[18, 19]. In the current study, CSC sphere formation was 
compared between culture conditions including medium 
with growth factors and with FBS. Spheres formed well 
under both media conditions, and the characteristics of 
CSCs were not significantly different between the two 
media conditions. The proliferation rate of the cells in 
DMEM(+)GF was higher than that of cells in DMEM(+)
FBS after 3  days in culture. It is possible that cells pro-
liferated more rapidly in DMEM(+)GF due to the influ-
ence of the added growth factors. However, because the 
difference in cell proliferation between the DMEM(+)
GF and DMEM(+)FBS was minimal after 15  days, we 
hypothesized that growth factors may affect prolifera-
tion initially but less so subsequently. Additionally, both 
groups had low proliferation rates as the culture period 
was extended, indicating that apoptosis occurred. Cells in 
DMEM(−)FBS did not form spheres or proliferate, and 
most of the cells died in culture. Therefore, DMEM(−)
FBS medium was excluded from further experiments.
The expression levels of CSC and stem cell markers 
were not significantly different between the DMEM(+)
GF and DMEM(+)FBS conditions. Pluripotent stem cell 
markers were minimally expressed at the beginning of 
culture but increased after days 15 and 20 in both experi-
mental groups. Oct4, Nanog, and Sox2 expression was 
evaluated, and the results showed no significant differ-
ence between DMEM(+)GF and DMEM(+)FBS cul-
tured cells. Oct4 and Nanog were highly expressed in 
DMEM(+)GF cells at the beginning of culture. Cells cul-
tured in DMEM(+)FBS did not express Oct4 and Nanog 
early in culture; however, over time, this expression 
increased to be similar to that in DMEM(+)GF-cultured 
cells. From these results, we concluded that addition of 
growth factors does not affect the pluripotency charac-
teristics of cells over time. EpCAM is a prognostic factor 
used as a biomarker for early HCC that is also expressed 
in stem cells [20]. EpCAM was expressed strongly in both 
experimental groups, indicating further that the cells 
maintained characteristics of CSCs in culture.
β-catenin is a signaling molecule involved in the pro-
liferation and differentiation of hepatoblasts. Increased 
expression of β-catenin results in increased proliferation 
and growth of hepatoblastoma and HCC cells [21]. In the 
current experiment, cells grown under both media condi-
tions expressed β-catenin, indicating cellular proliferation.
Connexin 32 and CD133 are widely used stem cell 
markers that are identified in cancer tissues such as those 
of the liver, brain and pancreas to promote tumor metas-
tasis and CSC expansion and self-renewal [11, 22].
DMEM(+)GF and DMEM(+)FBS cultured cells showed 
expression of Connexin 32 at similar levels. In addition, 
flow cytometry revealed that the number of sphere-form-
ing cells expressing CD133 was not different between the 
two media conditions. The HCC marker CD90 was also 
expressed in both groups, suggesting that the cells may 
have properties similar to CSCs causing carcinogenesis.
In the both cell lines, the ratio of cells expressing 
CD133 greatly decreased on day 20. This result suggests 
that CD133 expression cells can be differentiated, which 
is a typical characteristic of stem cell line. The continuous 
addition of growth factor and serum have turned CD133 
expressing cells into non-CD133 expressing cells. Previ-
ous studies have reported that in the hepatoma cell k\
line CD133 and EpCAM expression cells differentiated 
into non-CD133 and non-EpCAM expressing cells as 
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the days of culture increased [23]. We have shown that 
sphere-forming culture of CSCs can be performed in 
growth factor-free medium supplemented with serum 
with the cells maintaining characteristics of CSCs. Our 
results suggest that the addition of growth factors does 
not affect the characteristics or proliferation of CSCs in 
long-term culture. Sphere-forming CSCs in solid cancer 
tissues are known to proliferate in serum-free medium 
supplemented with growth factors such as EGF and 
bFGF [12, 13]. However, in MCF7, a breast cancer cell 
Fig. 2 Expression of CSC markers in Huh7 and HepG2 spheres. a Huh7 and b HepG2 sphere-forming cells. Expression of gene levels were similar 
between the two groups. The expression of the housekeeping gene GAPDH was used as a loading control. Cx32 Connexin 32, Cx43 Connexin 43
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line, and A549, a lung cancer cell line, autocrine signaling 
in response to EGF increased in medium without these 
growth factors, and EGF receptors were activated to pro-
mote and increase CSC sphere formation. Conversely, 
it was found that suppression of bFGF increased CSC 
sphere formation [12].
Therefore, analysis of autocrine factors that may affect 
cell growth and proliferation is needed. Lastly, to identify 
the differentiation of CSCs into cancer cells, comparison 
of tumorigenesis by transplanting sphere-forming cells 
into animal models may be needed.
In conclusion, this study provides evidence that sphere-
forming CSCs can grow in culture without growth factors 
and maintain pluripotency. This finding may help reduce 
patients’ financial burden given that sphere-forming cul-
ture of CSCs may be conducted at a lower cost.
Fig. 3 Immunofluorescence staining showed that cancer stem cells markers were highly expressed in Huh7 (a) and HepG2 (b) sphere-forming 
cells. Sphere-forming cells showed they were positive for cancer stem cells markers of CD90 (red), CD133 (red), E-cadherin (red), β-catenin (green). 
Scale bar 100 µm
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Methods
Cell culture
Human hepatocellular carcinoma cells (Huh7, HepG2) 
were obtained from Korean Cell Line Back (Seoul, 
Korea). Cell lines (Huh7, HepG2) were cultured at a den-
sity of 10,000  cells/cm2 in Dulbecco’s Modified Eagle 
Medium (DMEM) high-glucose medium supplemented 
with 10  % inactivated fetal bovine serum (FBS), 0.01  % 
antibiotic–antimycotic (Invitrogen, Grand Island, NY, 
USA), and incubated at 37 °C with 5 % CO2.
Sphere‑forming culture
When cell confluence reached 80  %, the cells were 
detached using 1× trypsin–EDTA. Cells free from serum 
were suspended in DMEM/F12 medium supplemented 
with 1 % b27 supplement, 0.01 % antibiotic–antimycotic 
(Invitrogen, Grand Island, NY, USA), 20  ng/mL epi-
dermal growth factor [EGF (Invitrogen, Grand Island, 
NY, USA)], and 20  ng/mL basic fibroblast growth fac-
tor [bFGF (Invitrogen, Seoul, Korea)] (DMEG(+)GF), 
DMEM-high glucose with FBS(DMEM(+)FBS and 
DMEM-high glucose without FBS(DMEM(−)FBS). 
Cells were subsequently cultured in ultra-low attach-
ment 24-well plates (24 well plate coated with Ultra-Low 
Attachment Surface, Corning, NY, USA) at a density of 
10,000 cells per well, and were incubated at 37  °C with 
5 % CO2.
Cell morphology
After sphere-forming culture, a photo of each media con-
dition was observed with a microscope on days 3, 7, 15, 
and 20 to observe cell morphology.
Cell proliferation assay
Cell proliferation rates were measured for cells in each 
medium type with an enzyme-linked immunosorbent 
assay (ELISA) reader using Cell Counting Kit-8 from 
Dojindo Laboratories (Kumamoto, Japan). Cell density 
was measured at an absorbance of 450 nm on days 3, 7, 
15, and 20.
Reverse transcription‑polymerase chain reaction (RT‑PCR)
Cells were collected from each culture medium type at 
days 3, 7, 15, and 20. Total mRNA was extracted from 
the cells using TRIzol reagent (Invitrogen, CA, USA). 
cDNA was produced from 2 μg of RNA using RT-PCR, 
and PCR amplification was performed. Gene expression 
was visualized using 1.6  % agarose gel electrophore-
sis. RT-PCR primer sequences are described in Table 1. 
The degree of expression for each marker was compared 
Fig. 4 Expression of pluripotency and cancer stem cells markers in sphere-forming cells. Oct4, Nanog, Sox2 were increased similar to the number of 
Huh7 (a) and HepG2 (b) sphere-forming cells in both media. c Huh7 sphere-forming cells were positive for CD133, Connexin 32. d HepG2 sphere-
forming cells were positive for CD133 and Connexin 32
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using Image J (National Institutes of Health, Bethesda, 
MD, USA).
Immunocytochemistry
Cells were collected from each medium type at days 
7, 15, and 20. Cells were washed in phosphate-buffered 
saline (PBS) and immediately fixed in 10 % formaldehyde 
solution. Each cell sample was exposed to CD133, CD90, 
E-cadherin, and beta-catenin primary antibodies. After 
a 24-h incubation, the anti-rabbit IgG HRL-F (ab) and 
2-PE anti-goat IgG-FITC (Santa Cruz, TX, USA) second-
ary antibodies were attached. Antibodies are described in 
Table 2. Immunostained cells were observed with a fluo-
rescence microscope.
For confocal microscopy, cells were fixed in glass 
chamber slides with 10  % paraformaldehyde in PBS for 
30 min at room temperature. After two washes with PBS, 
cells were permeabilized with 100 % methanol for 5 min 
at room temperature. Cells were washed twice with PBS 
and blocked for 45  min in 5  % bovine serum albumin 
(BSA) in PBS. Confocal microscopy studies were carried 
out using a laser-scanning microscope from OLYMPUS 
(Tokyo, Japan).
Flow cytometry
The sphere-forming cells were separated into single cells 
using 1× trypsin–EDTA, centrifuged to precipitate, and 
cleansed with 0.5  % BSA and 2  mM EDTA in PBS. PE-
conjugated antihuman CD133/2 monoclonal antibody 
(mAb) (Miltenyi Biotec, Bergisch Gladbach, Germany) 
was then added. After acquiring a cell pellet with the 
method described above, the primary antibody specific 
to Connexin 32 was incubated with the pellet at 4 °C for 
24  h. The secondary antibody was incubated at room 
temperature for 1 h, and the fluorescence was measured 
using flow cytometry. BD Human pluripotent stem cell 
transcription factor analysis kit (BD Biosciences, San 
Jose, CA, USA) was used to measure the pluripotency 
markers Oct4, Nanog, and Sox2.
Abbreviations
Oct4: octamer-binding transcription factor 4; Sox2: SRY (sex determining 
region Y)-box 2; EpCAM: epithelial cellular adhesion molecule; GAPDH: glycer-
aldehyde 3-phosphate dehydrogenase.
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Table 1 Primer used for RT-PCR
Gene name Primer sequence Product size 
(bp)
Accession no. Annealing tem‑
perature
Number 
of cycles
OCT 4 S 5′-CGT GAA GCT GGA GAA GGA GAA GCT-3′ 245 AF268617 60 34
A 5′-CAA GGG CCG CAG CTC ACA CAT GTT C-3′
NANOG S 5′-CAA AGG CAA ACA ACC CAC TT-3′ 394 NM_024865 60 34
A 5’-ATT GTT CCA GGT CTG GTT GC-3′
SOX 2 S 5′-AAC CCC AAG ATG CAC AAC TC-3′ 100 BC13923.2 60 34
A 5′-CGG GGC CGG TAT TTA TAA TC-3′
EpCAM S 5′-CTG GCC GTA AAC TGC TTT AG-3′ 182 BC014785.1 60 34
A 5′-AGC CCA TCA TTG TTC TGG AG-3′
Connexin 32 S 5′-GTT TGA GGC CGT CTT CAT GT-3′ 188 BC039198.1 60 34
A 5′-CCA CAT TGA GGA TGA TGC AG-3′
Connexin 43 S 5′-GGA CAT GCA CTT GAA GCA GA-3′ 103 BC026329.1 60 34
A 5′-GAT GAT GTA GGT TCG CAG CA-3′
GAPDH S 5′-TCC ATG ACA ACT TTG TGA TC-3′ 452 NM_002046 55 34
A 5′-TGT AGC CAA ATT CGT TGT TA-3′
Table 2 Antibodies used for immunocytochemistry
First antibody (1:300 dilution) Secondary antibody  
(1:300 dilution)
Rabbit anti-human E-cadherin antibody 
(Santa Cruz)
Anti-rabbit IgG HRL-F(ab)2-PE 
(Santa Cruz)
Rabbit anti-human CD90 antibody 
(Santa Cruz)
Anti-rabbit IgG HRL-F(ab)2-PE 
(Santa Cruz)
Goat anti-human beta-catenin antibody 
(Santa Cruz)
Anti-goat IgG-FITC (Santa Cruz)
Goat anti-human CD133 antibody 
(Santa Cruz)
Anti-goat IgG-FITC (Santa Cruz)
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